Abstract: A method for protecting memory segments of a memory device is provided. The method includes receiving, by a processor coupled to the memory device, a request to allocate memory from an application, being executed by the processor, wherein the request includes a requested memory size and allocating, by the processor, a portion of memory having a size greater than the requested memory size. The method also includes creating, by the processor, a permitted read counter associated with the allocated portion of memory, wherein the permitted read counter is initialized to an initial value, and determining, by the processor, whether access to the memory segment is permitted using the permitted read counter. A system for protecting memory segments of a memory device is also disclosed.

Abstract: A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam, or a pharmaceutically acceptable salt thereof, delivered as an aerosol or dry powder formulation.

Abstract: A method for verifying memory device integrity includes identifying at least one memory block corresponding to at least one memory location within a memory device. The memory block is associated with a prior checksum. It is determined whether the first memory block is designated read-only. A current checksum is calculated based at least in part on data within the memory block. When the first memory block is designated read-only, and the prior checksum represents expected data within the first memory block, it is determined whether the current checksum is equal to the prior checksum. When the current checksum is not equal to the prior checksum, a verification failure for the first memory block is indicated via a notification interface. A system for verifying memory device integrity is also disclosed.

Abstract: A method and system for verifying memory device integrity includes identifying at least one memory block corresponding to at least one memory location within a memory device. The memory block is associated with a portion of a file and a checksum representing data within the memory block at a first time. Based at least in part on determining that the memory block is mapped to the same portion of the same file at a second time, it is indicated that the checksum represents expected data within the memory block. A system for verifying memory device integrity is also disclosed.

Abstract: A method for improvement of tolerance for therapeutically effective agents delivered by inhalation comprising a pretreatment of a patient with a nebulized lidocaine or a lidocaine-like compound administered immediately or up to about thirty minutes before administration of the primary therapeutically effective agent. The pretreatment of the patient with the nebulized lidocaine or a lidocaine-like compound improves airway tolerance and deposition of the agent in the lungs and makes such deposition more safe, efficacious, controllable and predictable. The method of the invention is especially useful for enhancement of deposition of immunosuppressive agents in the lung(s) of transplant patients, improved tolerance of the drugs by reducing cough, and improving pulmonary drug deposition.

Abstract: An anti-tussive nebulized solution for targeted delivery of lidocaine into conducting and central airways. A method for treatment of cough and tussive attacks or episodes using said lidocaine solution. A nebulized lidocaine solution administered in daily dose from about 10 mg to 80 mg of lidocaine dissolved in a saline and nebulized into an aerosol having a mass median aerodynamic diameter 3 ?m to 10 ?m and a geometric standard deviation less than 1.7 using an electronic nebulizer.

Abstract: A method for determining a physical property of an object in a multi-path clutter environment comprises transmitting an RF interrogation signal to a wireless sensor physically coupled to the object or the fluid in the multi-path clutter environment, wherein the wireless sensor is operable to receive the RF interrogation signal, produce a reference signal and a measurement signal, and transmit the reference signal and the measurement signal in the multi-path clutter environment. The reference signal and measurement signal are delayed by the wireless sensor by an amount of time that may be a function of the unknown physical property. The method also comprises receiving the transmitted reference signal and the transmitted measurement signal and comparing them in the time domain in order to determine the unknown physical property of the object or the fluid.

Abstract: Antenna assemblies and corresponding modes of operation are provided where the first antenna assembly of the system is tuned to a first frequency band ?1 and the second antenna assembly of the antenna system is tuned to a second frequency band ?2. The ground plane of the first antenna assembly is configured as a frequency selective surface that is substantially reflective of radiation in the first frequency band and substantially transparent to radiation in the second frequency band. The second ground plane may also be configured as a frequency selective surface and may be reflective of radiation in the second frequency band. Any number of additional antenna arrays may be added so long as the outer arrays are transparent to the inner arrays.

Abstract: An anti-tussive nebulized solution for targeted delivery of lidocaine into conducting and central airways. A method for treatment of cough and tussive attacks or episodes using said lidocaine solution. A nebulized lidocaine solution administered in daily dose from about 10 mg to 80 mg of lidocaine dissolved in a saline and nebulized into an aerosol having a mass median aerodynamic diameter 3 ?m to 10 ?m and a geometric standard deviation less than 1.7 using an electronic nebulizer.

Abstract: A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam lysinate delivered as an aerosol or dry powder formulation.